Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €100.15 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €16.68 | - | - |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.63 | €3.70 | 127.412% |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.98 | €4.62 | -7.252% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €10.09 | €22.78 | 125.722% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.72 | €26.01 | 31.878% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €29.20 | €41.81 | 43.199% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.44 | €50.33 | 24.463% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.71 | €55.00 | 6.362% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | €126.15 | €140.34 | 11.249% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.35 | €184.76 | 22.075% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €139.00 | €236.30 | 69.999% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €361.00 | €421.61 | 16.788% |